A detailed history of Massachusetts Financial Services CO transactions in Dexcom Inc stock. As of the latest transaction made, Massachusetts Financial Services CO holds 1,430,964 shares of DXCM stock, worth $115 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
1,430,964
Previous 2,439,033 41.33%
Holding current value
$115 Million
Previous $277 Million 65.32%
% of portfolio
0.03%
Previous 0.09%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$64.0 - $116.06 $64.5 Million - $117 Million
-1,008,069 Reduced 41.33%
1,430,964 $95.9 Million
Q2 2024

Aug 09, 2024

BUY
$110.31 - $140.45 $38.9 Million - $49.6 Million
353,019 Added 16.92%
2,439,033 $277 Million
Q1 2024

May 14, 2024

BUY
$114.22 - $140.1 $24.9 Million - $30.6 Million
218,229 Added 11.68%
2,086,014 $289 Million
Q4 2023

Feb 08, 2024

BUY
$75.49 - $124.16 $141 Million - $232 Million
1,867,785 New
1,867,785 $232 Million
Q1 2021

May 13, 2021

SELL
$84.79 - $104.74 $1.4 Million - $1.73 Million
-16,563 Closed
0 $0
Q4 2020

Feb 12, 2021

SELL
$78.0 - $104.5 $27 Million - $36.2 Million
-346,400 Reduced 95.44%
16,563 $6.12 Million
Q3 2020

Nov 12, 2020

SELL
$95.51 - $112.95 $2.72 Million - $3.21 Million
-28,450 Reduced 7.27%
362,963 $150 Million
Q2 2020

Aug 11, 2020

BUY
$62.68 - $105.34 $5.09 Million - $8.56 Million
81,224 Added 26.19%
391,413 $159 Million
Q1 2020

May 14, 2020

BUY
$47.79 - $75.63 $3.78 Million - $5.98 Million
79,079 Added 34.22%
310,189 $83.5 Million
Q4 2019

Feb 13, 2020

BUY
$36.62 - $57.29 $1.12 Million - $1.75 Million
30,611 Added 15.27%
231,110 $50.6 Million
Q3 2019

Nov 05, 2019

BUY
$35.53 - $43.8 $588,661 - $725,678
16,568 Added 9.01%
200,499 $29.9 Million
Q2 2019

Aug 14, 2019

SELL
$27.84 - $38.92 $2.6 Million - $3.63 Million
-93,330 Reduced 33.66%
183,931 $27.6 Million
Q1 2019

May 13, 2019

BUY
$28.07 - $38.18 $1.15 Million - $1.56 Million
40,961 Added 17.33%
277,261 $33 Million
Q4 2018

Feb 08, 2019

BUY
$26.99 - $37.37 $1.07 Million - $1.49 Million
39,741 Added 20.22%
236,300 $28.3 Million
Q3 2018

Oct 25, 2018

SELL
$23.35 - $36.72 $421,841 - $663,383
-18,066 Reduced 8.42%
196,559 $28.1 Million
Q2 2018

Jul 30, 2018

SELL
$17.54 - $25.22 $3.31 Million - $4.76 Million
-188,911 Reduced 46.81%
214,625 $20.4 Million
Q1 2018

May 04, 2018

SELL
$13.06 - $18.54 $2.08 Million - $2.95 Million
-159,077 Reduced 28.27%
403,536 $29.9 Million
Q4 2017

Feb 14, 2018

BUY
$11.12 - $15.38 $167,634 - $231,853
15,075 Added 2.75%
562,613 $32.3 Million
Q3 2017

Nov 14, 2017

BUY
$11.36 - $18.98 $1.53 Million - $2.56 Million
135,022 Added 32.73%
547,538 $26.8 Million
Q2 2017

Aug 14, 2017

BUY
N/A
412,516
412,516 $30.2 Million

Others Institutions Holding DXCM

About DEXCOM INC


  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $31B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track Massachusetts Financial Services CO Portfolio

Follow Massachusetts Financial Services CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Massachusetts Financial Services CO , based on Form 13F filings with the SEC.

News

Stay updated on Massachusetts Financial Services CO with notifications on news.